DE69740072D1 - Menschliches wachstumshormon zur behandlung von anorexia nervosa - Google Patents
Menschliches wachstumshormon zur behandlung von anorexia nervosaInfo
- Publication number
- DE69740072D1 DE69740072D1 DE69740072T DE69740072T DE69740072D1 DE 69740072 D1 DE69740072 D1 DE 69740072D1 DE 69740072 T DE69740072 T DE 69740072T DE 69740072 T DE69740072 T DE 69740072T DE 69740072 D1 DE69740072 D1 DE 69740072D1
- Authority
- DE
- Germany
- Prior art keywords
- growth hormone
- anorexia nervosa
- treatment
- nutrition
- human growth
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Expired - Lifetime
Links
- 208000000103 Anorexia Nervosa Diseases 0.000 title abstract 3
- 102000002265 Human Growth Hormone Human genes 0.000 title abstract 3
- 108010000521 Human Growth Hormone Proteins 0.000 title abstract 3
- 239000000854 Human Growth Hormone Substances 0.000 title abstract 3
- 235000016709 nutrition Nutrition 0.000 abstract 3
- 230000035764 nutrition Effects 0.000 abstract 3
- 102000038461 Growth Hormone-Releasing Hormone Human genes 0.000 abstract 2
- 239000000095 Growth Hormone-Releasing Hormone Substances 0.000 abstract 2
- 101710142969 Somatoliberin Proteins 0.000 abstract 2
- 239000003814 drug Substances 0.000 abstract 2
- 229940124597 therapeutic agent Drugs 0.000 abstract 2
- 208000030814 Eating disease Diseases 0.000 abstract 1
- 208000019454 Feeding and Eating disease Diseases 0.000 abstract 1
- 208000028017 Psychotic disease Diseases 0.000 abstract 1
- 206010047700 Vomiting Diseases 0.000 abstract 1
- 230000002159 abnormal effect Effects 0.000 abstract 1
- 235000014632 disordered eating Nutrition 0.000 abstract 1
- 235000005686 eating Nutrition 0.000 abstract 1
- 230000020595 eating behavior Effects 0.000 abstract 1
- 238000009472 formulation Methods 0.000 abstract 1
- 239000000203 mixture Substances 0.000 abstract 1
- 230000028327 secretion Effects 0.000 abstract 1
- 208000024891 symptom Diseases 0.000 abstract 1
- 229940125725 tranquilizer Drugs 0.000 abstract 1
- 239000003204 tranquilizing agent Substances 0.000 abstract 1
- 230000002936 tranquilizing effect Effects 0.000 abstract 1
- 230000008673 vomiting Effects 0.000 abstract 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
- A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- A61K38/22—Hormones
- A61K38/27—Growth hormone [GH], i.e. somatotropin
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/04—Anorexiants; Antiobesity agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P5/00—Drugs for disorders of the endocrine system
- A61P5/02—Drugs for disorders of the endocrine system of the hypothalamic hormones, e.g. TRH, GnRH, CRH, GRH, somatostatin
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Endocrinology (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Chemical & Material Sciences (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Medicinal Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- General Health & Medical Sciences (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Immunology (AREA)
- Zoology (AREA)
- Diabetes (AREA)
- Gastroenterology & Hepatology (AREA)
- Epidemiology (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Neurosurgery (AREA)
- Biomedical Technology (AREA)
- Child & Adolescent Psychology (AREA)
- Neurology (AREA)
- Hematology (AREA)
- Obesity (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Transition And Organic Metals Composition Catalysts For Addition Polymerization (AREA)
- Confectionery (AREA)
- Steroid Compounds (AREA)
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| JP20124896 | 1996-07-10 | ||
| PCT/JP1997/002283 WO1998001152A1 (fr) | 1996-07-10 | 1997-07-02 | Medicaments pour les troubles alimentaires |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| DE69740072D1 true DE69740072D1 (de) | 2011-01-20 |
Family
ID=16437800
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| DE69740072T Expired - Lifetime DE69740072D1 (de) | 1996-07-10 | 1997-07-02 | Menschliches wachstumshormon zur behandlung von anorexia nervosa |
Country Status (7)
| Country | Link |
|---|---|
| US (1) | US6225283B1 (de) |
| EP (1) | EP0916345B1 (de) |
| JP (1) | JP4171070B2 (de) |
| AT (1) | ATE490780T1 (de) |
| AU (1) | AU3357997A (de) |
| DE (1) | DE69740072D1 (de) |
| WO (1) | WO1998001152A1 (de) |
Families Citing this family (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| JP2007502841A (ja) * | 2003-08-20 | 2007-02-15 | ニューレン ファーマシューティカルズ リミテッド | 成長ホルモンの２０ｋＤａ胎盤性変種を用いる体形成療法 |
Family Cites Families (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| WO1995024919A1 (en) | 1994-03-15 | 1995-09-21 | K.U. Leuven Research & Development | New use of growth hormone |
| AU693478B2 (en) | 1994-11-10 | 1998-07-02 | Metabolic Pharmaceuticals Limited | Treatment of obesity |
-
1997
- 1997-07-02 AU AU33579/97A patent/AU3357997A/en not_active Abandoned
- 1997-07-02 EP EP97929492A patent/EP0916345B1/de not_active Expired - Lifetime
- 1997-07-02 AT AT97929492T patent/ATE490780T1/de not_active IP Right Cessation
- 1997-07-02 JP JP50503898A patent/JP4171070B2/ja not_active Expired - Fee Related
- 1997-07-02 DE DE69740072T patent/DE69740072D1/de not_active Expired - Lifetime
- 1997-07-02 WO PCT/JP1997/002283 patent/WO1998001152A1/ja active Application Filing
- 1997-07-02 US US09/214,597 patent/US6225283B1/en not_active Expired - Lifetime
Also Published As
| Publication number | Publication date |
|---|---|
| US6225283B1 (en) | 2001-05-01 |
| WO1998001152A1 (fr) | 1998-01-15 |
| AU3357997A (en) | 1998-02-02 |
| EP0916345B1 (de) | 2010-12-08 |
| JP4171070B2 (ja) | 2008-10-22 |
| EP0916345A4 (de) | 2008-08-06 |
| ATE490780T1 (de) | 2010-12-15 |
| EP0916345A1 (de) | 1999-05-19 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| DE69739792D1 (de) | Verfahren zur Behandlung von Augenerkrankungen | |
| EP1201241B8 (de) | Zusammensetzungen enthaltend Capsaicin oder Capsaicin Analoge und ein Anästhetikum | |
| DE60138547D1 (de) | Topisch anwendbare arzneipräparate und verfahren zur behandlung | |
| ATE240723T1 (de) | Transdermale therapeutische vorrichtung mit capsaicin und seinen analogen | |
| ATE399553T1 (de) | Pharmazeutische zusammensetzungen mit dextromethorphan und chinidin zur behandlung von neurologischen erkrankungen | |
| ATE144420T1 (de) | Verwendung von riluzol zur behandlung von parkinson und den parkinson-syndromen | |
| ATE277638T1 (de) | Zubereitungen zur behandlung von gastrointestinalen störungen, welche arabinogalactan und polyphenole von larix enthalten. | |
| ATE170769T1 (de) | Vorrichtung zur verabreichung von medikamenten durch elektrotransport | |
| AU1865100A (en) | Hyaluronate lyase used for promoting penetration in topical agents | |
| ATE141505T1 (de) | Verwendung von 3-guanidinopropionsäure zur herstellung eines medikaments zur behandlung und prävention von fettsucht | |
| UA35567C2 (uk) | Фармацевтичний препарат для лікування хворих з порушеннями функції коагуляції, спосіб лікування таких хворих, спосіб одержання фармацевтичного препарату | |
| MX9701187A (es) | Nuevas lactamas naftofusionadas n-substituidas. | |
| BR9607541A (pt) | Tratamento de doenças que tem por causa o fator de crescimento da citoquina | |
| ATE454451T1 (de) | Methode zur behandlung von muskelkrankheiten | |
| DE60119976D1 (en) | Thixotropes nasenspray | |
| ATE183651T1 (de) | Verwendung von wachstumsfaktor igf-ii zur beahandlung von gastrointestinalen störungen | |
| BR9808114A (pt) | Formulação de ração para cavalos utilizável para tratar epm, processos para tratar pm em um cavalo que necessita deste tratamento, para prevenir infecção com s. neutrona em cavalos, e, para exterminar s. neurona em cavalos | |
| ATE490780T1 (de) | Menschliches wachstumshormon zur behandlung von anorexia nervosa | |
| DE69924483D1 (de) | Kombinationstherapie zur behandlung von tumoren | |
| ATE311897T1 (de) | Behandlung von multiplersklerose mit einer kombination von interferon und wachstumshormone | |
| WO2000078328A3 (de) | VERWENDUNG VON WACHSTUMSHORMON (hGH) ZUR THERAPIE SEXUELLER FUNKTIONSSTÖRUNGEN | |
| ATE279939T1 (de) | Phytase zur vorbeugung oder behandlung von mastitis | |
| DE60024969D1 (de) | 2-methyl-3-butenyl-1-pyrophosphorsäuresalze und mittel zur behandlung von lymphozyten | |
| DE69803298D1 (de) | Verwendung des wachstumshormons in mitteln zur behandlung der insulinresistenz im herzen | |
| DE60327179D1 (de) | Behandlung von augenkrankheiten mit harnstoff und harnstoffderivaten |